Quick Answer
MedWellAI, Inc. reported Total Revenue of $594.8 thousand for fiscal year 2025.
MedWellAI, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $594.8K | $0.00 -100.0% |
$3.86M -41.0% |
$6.55M +253.8% |
$1.85M +307.6% |
$454.2K +62.7% |
| Net Income | -$3.61M +68.7% |
-$11.52M +54.7% |
-$25.46M -4402.1% |
-$565.5K +97.5% |
-$22.43M -1973.7% |
-$1.08M +88.6% |
| Diluted EPS | — | -$2.72 +77.3% |
-$11.98 | — | — | — |
| Total Assets | $805.5K -79.6% |
$3.94M -40.2% |
$6.59M -59.5% |
$16.28M +21.8% |
$13.36M +2343.9% |
$546.8K -51.2% |
| Cash and Equivalents | — | $57.8K -77.6% |
$258.0K -47.4% |
$490.3K -76.6% |
$2.10M +31323.8% |
$6.7K -86.2% |
| Stockholders Equity | -$6.62M -71.4% |
-$3.87M -658.1% |
-$509.9K -104.8% |
$10.59M +18.2% |
$8.96M +8279.4% |
-$109.6K +89.9% |
| R&D Expense | — | — | — | — | — | — |
| Operating Income | -$2.84M +68.7% |
-$9.07M +64.0% |
-$25.17M -3558.7% |
-$688.0K +96.8% |
-$21.67M -2035.6% |
-$1.01M +78.2% |
| Gross Profit | — | — | -$2.43M -190.8% |
$2.68M +188.0% |
$931.0K +271.7% |
-$542.2K +25.3% |
| Shares Outstanding | 6.19M +22.2% |
5.06M +76.8% |
2.86M +72.8% |
1.66M -99.1% |
194.49M +88.5% |
103.16M -47.0% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | December 31, 2025 | $548.3K | +283.8% | +470.6% |
| Net Income | December 31, 2025 | -$287.5K | +57.3% | +55.9% |
| Diluted EPS | March 31, 2025 | -$0.10 | -1100.0% | +23.1% |
| Total Assets | December 31, 2025 | $460.9K | -83.6% | -16.2% |
| Cash and Equivalents | September 30, 2023 | $57.7K | — | -77.6% |
| Long-Term Debt | December 31, 2020 | $328.0K | — | +124.1% |
| Stockholders Equity | December 31, 2025 | -$7.45M | -36.5% | -3.1% |
| R&D Expense | December 31, 2016 | $738.00 | -63.5% | -94.7% |
| Operating Income | December 31, 2025 | -$274.0K | +13.0% | +16.0% |
| Gross Profit | December 31, 2023 | -$189.4K | +38.6% | +63.2% |
| Shares Outstanding | December 31, 2025 | 6.24M | +19.1% | +0.0% |
- MedWellAI, Inc. reported Total Revenue of $594.8 thousand for fiscal year 2025.
- MedWellAI, Inc. reported Net Income of -$3.61 million for fiscal year 2025.
- MedWellAI, Inc. showed an increase of +68.7% in Net Income compared to the prior fiscal year.
- MedWellAI, Inc. reported Diluted EPS of $2.72 per share (loss) for fiscal year 2024.
- MedWellAI, Inc. showed an increase of +77.3% in Diluted EPS compared to the prior fiscal year.
- MedWellAI, Inc. reported Total Assets of $805.5 thousand for fiscal year 2025.
- MedWellAI, Inc. showed a decrease of -79.6% in Total Assets compared to the prior fiscal year.
- MedWellAI, Inc. reported Cash and Equivalents of $57.8 thousand for fiscal year 2024.
- MedWellAI, Inc. showed a decrease of -77.6% in Cash and Equivalents compared to the prior fiscal year.
- MedWellAI, Inc. reported Stockholders Equity of -$6.62 million for fiscal year 2025.
- MedWellAI, Inc. showed a decrease of -71.4% in Stockholders Equity compared to the prior fiscal year.
- MedWellAI, Inc. reported R&D Expense of $21.6 thousand for fiscal year 2017.
- MedWellAI, Inc. showed a decrease of -82.0% in R&D Expense compared to the prior fiscal year.
- MedWellAI, Inc. reported Operating Income of -$2.84 million for fiscal year 2025.
- MedWellAI, Inc. showed an increase of +68.7% in Operating Income compared to the prior fiscal year.
- MedWellAI, Inc. reported Gross Profit of -$2.43 million for fiscal year 2023.
- MedWellAI, Inc. showed a decrease of -190.8% in Gross Profit compared to the prior fiscal year.
- MedWellAI, Inc. reported Shares Outstanding of 6.19 million shares for fiscal year 2025.
- MedWellAI, Inc. showed an increase of +22.2% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: